Hospital Universitario Getafe
39
5
5
27
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
2.6%
1 terminated/withdrawn out of 39 trials
96.4%
+9.9% vs industry average
13%
5 trials in Phase 3/4
7%
2 of 27 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (39)
Caffeine Consumption and Rate Control in Permanent Atrial FIBrillation: The CAFIB Trial
Role: lead
Long-term Atogepant in Real-world Practice
Role: collaborator
Validation of an App in the Elderly Population With Diabetes Mellitus.
Role: collaborator
Development of Continuous Assessment of Frailty and Muscle Quality in Older Subjects: ECOFRAIL Protocol
Role: collaborator
Motivational Support for an Autonomous Exercise Program for Healthy Aging
Role: lead
Augmented Reality as Discharge Information for Hospitalized Cardiology Patients
Role: lead
Adaptation and Validation of Frailty Scales in Intensive Care Units in Spain
Role: lead
Analysis of the Evolution of Mortality in an Intensive Care Unit
Role: lead
Characterization of the Intestinal and Vaginal Microbiota in Long-term Survivors of Gynecological Cancer
Role: collaborator
Biomarkers of Inflammation and Endothelial Dysfunction in Patients With Myocardial Infarction With Non-obstructive Coronary Arteries
Role: lead
Global BurdEn of MechanIcal VeNtilatIon (GEMINI). VeNtilatIon (GEMINI Study) 2022 for VENTILAGROUP.
Role: lead
Mesenchymal Stem Cell Based Therapy for the Treatment of Osteogenesis Imperfecta
Role: collaborator
Clinical Intervention in Frail Older People (FRAILCLINIC)
Role: lead
Sarcopenia Measured by Ultrasound in Hospitalized Older Adults
Role: collaborator
Early Physiotherapy in Covid Patients
Role: lead
Reaching Consensus on the Definition of Difficult Cholecystectomy
Role: collaborator
Analysis of Mortality of Critically Ill Patients With COVID-19
Role: lead
Maintaining and imPrOving the intrinSIc capaciTy Involving Primary Care and caregiVErs
Role: lead
Low-dose Lenalidomide for Non-severe COVID-19 Treatment Trial
Role: lead
Fourth International Study of Mechanical Ventilation From VENTILA GROUP
Role: lead